Studies on in-vitro transcutaneous delivery of losartan potassium, influence of penetration enhancers and barrier membrane

Formulation and in vitro evaluation of losartan potassium (LP) loaded transdermal delivery system (TDS) was investigated for controlled release and improved therapeutic efficacy. TDS (patches) were prepared by varying the composition of Eudragit RL 100 and Eudragit RS 100 (5:0, 4:1, 3:2, 2.5:2.5, 2:...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Petkar, Kailash C., Pore, Yogesh V., Kuchekar, Bhanudas S.
Formato: Articulo
Lenguaje:Inglés
Publicado: 2011
Materias:
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/8278
http://www.latamjpharm.org/resumenes/30/6/LAJOP_30_6_1_20.pdf
Aporte de:
id I19-R120-10915-8278
record_format dspace
institution Universidad Nacional de La Plata
institution_str I-19
repository_str R-120
collection SEDICI (UNLP)
language Inglés
topic Farmacia
Hipertensión
capsaicin; eudragit; losartan potassium; pluronic F-68; sex; skin; transdermal delivery
Sistemas de Liberación de Medicamentos
spellingShingle Farmacia
Hipertensión
capsaicin; eudragit; losartan potassium; pluronic F-68; sex; skin; transdermal delivery
Sistemas de Liberación de Medicamentos
Petkar, Kailash C.
Pore, Yogesh V.
Kuchekar, Bhanudas S.
Studies on in-vitro transcutaneous delivery of losartan potassium, influence of penetration enhancers and barrier membrane
topic_facet Farmacia
Hipertensión
capsaicin; eudragit; losartan potassium; pluronic F-68; sex; skin; transdermal delivery
Sistemas de Liberación de Medicamentos
description Formulation and in vitro evaluation of losartan potassium (LP) loaded transdermal delivery system (TDS) was investigated for controlled release and improved therapeutic efficacy. TDS (patches) were prepared by varying the composition of Eudragit RL 100 and Eudragit RS 100 (5:0, 4:1, 3:2, 2.5:2.5, 2:3, 1:4 and 0:5). Patches were evaluated for thickness, content uniformity, mechanical properties, moisture uptake and in vitro drug release. Technological parameters for all the formulations were found to be within the limit. In vitro studies showed relatively high permeation of LP (F1- 42.17 ± 1.13 %) from the formulation comprising 4:1 ratio of polymer. Inclusion of capsaicin (55.70 ± 1.55 %) and pluronic F-68 (70.88 ± 1.20 %) to formulation F1 resulted increased permeation of LP across human skin. In conclusion, this study demonstrated the potential of simple transdermal adhesive patch incorporating LP to deliver therapeutically useful dose in-vivo for the treatment of hypertension.
format Articulo
Articulo
author Petkar, Kailash C.
Pore, Yogesh V.
Kuchekar, Bhanudas S.
author_facet Petkar, Kailash C.
Pore, Yogesh V.
Kuchekar, Bhanudas S.
author_sort Petkar, Kailash C.
title Studies on in-vitro transcutaneous delivery of losartan potassium, influence of penetration enhancers and barrier membrane
title_short Studies on in-vitro transcutaneous delivery of losartan potassium, influence of penetration enhancers and barrier membrane
title_full Studies on in-vitro transcutaneous delivery of losartan potassium, influence of penetration enhancers and barrier membrane
title_fullStr Studies on in-vitro transcutaneous delivery of losartan potassium, influence of penetration enhancers and barrier membrane
title_full_unstemmed Studies on in-vitro transcutaneous delivery of losartan potassium, influence of penetration enhancers and barrier membrane
title_sort studies on in-vitro transcutaneous delivery of losartan potassium, influence of penetration enhancers and barrier membrane
publishDate 2011
url http://sedici.unlp.edu.ar/handle/10915/8278
http://www.latamjpharm.org/resumenes/30/6/LAJOP_30_6_1_20.pdf
work_keys_str_mv AT petkarkailashc studiesoninvitrotranscutaneousdeliveryoflosartanpotassiuminfluenceofpenetrationenhancersandbarriermembrane
AT poreyogeshv studiesoninvitrotranscutaneousdeliveryoflosartanpotassiuminfluenceofpenetrationenhancersandbarriermembrane
AT kuchekarbhanudass studiesoninvitrotranscutaneousdeliveryoflosartanpotassiuminfluenceofpenetrationenhancersandbarriermembrane
bdutipo_str Repositorios
_version_ 1764820488620605442